Skip to main content

Table 3 The associations between preoperative CRP, CYFRA 21-1, and clinicopathologic parameters (N = 130)

From: Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma

 

CRP (−), CYFRA 21-1 (−)

CRP (−),CYFRA 21-1 (+)

CRP (+),CYFRA 21-1 (−)

CRP (+),CYFRA 21-1 (+)

 
 

(n (%))

(n (%))

(n (%))

(n (%))

P value

Tumor stage

 Earlya (n = 45)

33 (73.3)

7 (15.6)

5 (11.1)

0 (0.0)

0.009 e

 Advancedb (n = 85)

52 (61.2)

1 (1.2)

22 (25.9)

10 (11.8)

 

Pathologic N stage

 N0 (n = 68)

47 (69.1)

7 (10.3)

12 (17.6)

2 (2.9)

0.012 e

 N1 (n = 25)

18 (72.0)

0 (0.0)

7 (28.0)

0 (0.0)

 

 N2 (n = 37)

20 (54.1)

1 (2.7)

8 (21.6)

8 (21.6)

 

Nodal status

 (−) metastasis, (−) ECS (n = 68)

47 (69.1)

7 (10.3)

12 (17.6)

2 (2.9)

0.006 e

 (+) metastasis, (−) ECS (n = 23)

18 (78.3)

0 (0.0)

5 (21.7)

0 (0.0)

 

 (+) metastasis, (+) ECS (n = 39)

20 (51.3)

1 (2.6)

10 (25.6)

8 (20.5)

 

Differentiation

 Well (n = 32)

20 (62.5)

1 (3.1)

9 (28.1)

2 (6.2)

0.734

 Moderate (n = 80)

55 (68.8)

6 (7.5)

13 (16.2)

6 (7.5)

 

 Poor (n = 18)

10 (55.6)

1 (5.6)

5 (27.8)

2 (11.1)

 

Pathologic tumor status

 Earlyc (n = 74)

56 (75.7)

8 (10.8)

10 (13.5)

0 (0.0)

<0.001 e

 Advancedd (n = 56)

29 (51.8)

0 (0.0)

17 (30.4)

10 (17.9)

 

Skin invasion

 No (n = 117)

80 (68.4)

8 (6.8)

22 (18.8)

7 (6.0)

0.006 e

 Yes (n = 13)

5 (38.5)

0 (0.0)

5 (38.5)

3 (23.1)

 

Bone invasion

 No (n = 105)

75 (71.4)

8 (7.6)

16 (15.2)

6 (5.7)

0.001 e

 Yes (n = 25)

10 (40.0)

0 (0.0)

11 (44.0)

4 (16.0)

 

Tumor depth ≥10 mm

 No (n = 60)

47 (78.3)

6 (10.0)

7 (11.7)

0 (0.0)

<0.001 e

 Yes (n = 70)

38 (54.3)

2 (2.9)

20 (28.6)

10 (14.3)

 
  1. CRP (−) CRP level <5.0 mg/L, CRP (+) CRP level ≥5.0 mg/L, CYFRA 21-1 (−) CYFRA 21-1 <3.3 ng/mL, CYFRA 21-1 (+) CYFRA 21-1 ≥3.3 ng/mL, ECS extra-capsular spread
  2. aStage I–II
  3. bStage III–IV
  4. cT1–T2
  5. dT3–T4
  6. eFisher’s exact test